Ikena Oncology Inc expected to post a loss of 36 cents a share - Earnings Preview

ImageneBio

10/08/2021 12:48

* Ikena Oncology Inc  IKNA.OQ   IKNA.O  is expected to report
results on August 12.
* The Boston, Massachusetts-based company is expected to report
revenue of $3.931 million, according to the mean estimate from 4
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Ikena Oncology Inc is
for a loss of 36 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Ikena Oncology
Inc is $28.5​, about 64.6% above​ its last closing price
of $10.09. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.68       -0.68      -2.52     Missed  -271.3
                                                        ​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 10 at 11:48 GMT.  All
figures in US dollars unless otherwise stated